Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-06 Sale | 2026-01-08 4:20 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 35,198 | $16.5 | $580,767 | 2,449,437 (Indirect Direct) | View |
| 2026-01-06 Sale | 2026-01-08 4:19 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 17,218 | $16.5 | $284,097 | 806,577 (Indirect Direct) | View |
| 2025-08-12 Sale | 2025-08-14 8:33 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 2,937 | $13.58 | $39,884 | 766,095 (Indirect Direct) | View |
| 2025-08-12 Sale | 2025-08-14 8:33 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 3,743 | $13.81 | $51,684 | 424,804 (Indirect Direct) | View |
| 2025-07-09 Sale | 2025-07-11 5:13 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 495,282 | $15 | $7,429,230 | 3,098,853 (Indirect Direct) | View |
| 2025-01-06 Sale | 2025-01-08 8:26 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 15,162 | $20.33 | $308,291 | 383,892 (Indirect Direct) | View |
| 2025-01-06 Sale | 2025-01-08 8:25 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 15,162 | $20.33 | $308,291 | 768,057 (Indirect Direct) | View |
| 2025-01-06 Sale | 2025-01-08 8:24 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 36,916 | $20.34 | $750,955 | 2,455,675 (Indirect Direct) | View |
| 2025-01-07 Sale | 2025-01-08 8:23 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 3,339 | $20.81 | $69,485 | 807,554 (Indirect Direct) | View |
| 2024-12-31 Sale | 2025-01-03 4:14 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 30,000 | $20.25 | $607,500 | 810,893 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-03 Option Award | 2026-06-05 4:46 pm | N/A 2036-06-03 | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 25,634 | $0 | 378,167 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:45 pm | N/A 2036-06-03 | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 25,634 | $0 | 53,167 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:45 pm | N/A 2036-06-03 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 25,634 | $0 | 839,225 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:45 pm | N/A 2036-06-03 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 25,634 | $0 | 98,355 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:45 pm | N/A 2036-06-03 | Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director | 25,634 | $0 | 50,351 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:44 pm | N/A 2036-06-03 | Denali Therapeutics Inc. | DNLI | Van Hauwermeiren Timothy Director | 25,634 | $0 | 36,266 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:43 pm | N/A 2036-06-03 | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 25,634 | $0 | 51,709 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:28 pm | N/A 2036-06-03 | Denali Therapeutics Inc. | DNLI | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 44,860 | $0 | 3,460,818 (Indirect) | View |
Ownership(A) | 2026-04-21 7:20 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Chin Peter Scott Chief Medical Officer | 0 | $0 | 204,402 (Direct) | View |
Ownership | 2026-04-20 7:22 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Chin Peter Scott Chief Medical Officer | 0 | $0 | 468,312 (Direct) | View |
| 2026-01-03 Option Award | 2026-01-05 6:49 pm | N/A 2036-01-03 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 230,800 | $0 | 996,895 (Direct) | View |
| 2026-01-03 Option Award | 2026-01-05 6:48 pm | N/A 2036-01-03 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 315,840 | $0 | 2,721,515 (Direct) | View |
| 2025-11-04 Option Award | 2025-11-06 8:16 pm | N/A 2034-11-04 | Denali Therapeutics Inc. | DNLI | Van Hauwermeiren Timothy Director | 42,529 | $0 | 42,529 (Direct) | View |
| 2025-09-03 Gift | 2025-09-05 4:43 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 50,000 | $0 | 2,405,675 (Indirect) | View |
| 2025-08-05 Exercise | 2025-08-07 5:34 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 44,655 | $0.68 | 491,047 (Direct) | View |
| 2025-08-05 Exercise | 2025-08-07 5:34 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 44,655 | $0 | 491,047 (Direct) | View |
| 2025-07-09 Exercise | 2025-07-11 5:13 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $5.28 | 3,098,853 (Direct) | View |
| 2025-07-09 Exercise | 2025-07-11 5:13 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 455,282 | $0.68 | 3,098,853 (Direct) | View |
| 2025-07-09 Exercise | 2025-07-11 5:13 pm | N/A 2025-08-21 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 495,282 | $0 | 3,098,853 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 5:02 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 73,955 | $0 | 3,479,348 (Indirect) | View |
Ownership | 2025-06-05 4:57 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 0 | $0 | 29,777,760 (Indirect) | View |
| 2025-06-03 Option Award | 2025-06-05 4:34 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 24,148 | $0 | 44,186 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:33 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 24,148 | $0 | 370,644 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:31 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 24,148 | $0 | 45,644 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:29 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 24,148 | $0 | 831,702 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:26 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 24,148 | $0 | 90,832 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:25 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director | 24,148 | $0 | 42,828 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:23 pm | N/A 2035-06-03 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 24,148 | $0 | 2,141,556 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:59 pm | N/A 2035-01-02 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 216,720 | $0 | 2,655,131 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:57 pm | N/A 2035-01-02 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 216,720 | $0 | 945,759 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 6:56 pm | N/A 2035-01-02 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 216,720 | $0 | 561,594 (Direct) | View |